- Home
- PCG vs HLN Comparison
PCG vs HLN Comparison
Compare PCG & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCG
- HLN
- Stock Information
- Founded
- PCG 1905
- HLN 2022
- Country
- PCG United States
- HLN United Kingdom
- Employees
- PCG N/A
- HLN N/A
- Industry
- PCG Power Generation
- HLN Package Goods/Cosmetics
- Sector
- PCG Utilities
- HLN Consumer Discretionary
- Exchange
- PCG Nasdaq
- HLN Nasdaq
- Market Cap
- PCG 35.3B
- HLN 43.3B
- IPO Year
- PCG N/A
- HLN N/A
- Fundamental
- Price
- PCG $16.41
- HLN $10.19
- Analyst Decision
- PCG Strong Buy
- HLN Strong Buy
- Analyst Count
- PCG 14
- HLN 2
- Target Price
- PCG $22.25
- HLN $10.48
- AVG Volume (30 Days)
- PCG 20.6M
- HLN 9.2M
- Earning Date
- PCG 04-24-2025
- HLN 02-27-2025
- Dividend Yield
- PCG 0.61%
- HLN 1.65%
- EPS Growth
- PCG 9.52
- HLN 38.94
- EPS
- PCG 1.15
- HLN 0.20
- Revenue
- PCG $24,419,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- PCG $6.81
- HLN $5.66
- Revenue Next Year
- PCG $2.99
- HLN $4.86
- P/E Ratio
- PCG $14.26
- HLN $25.34
- Revenue Growth
- PCG N/A
- HLN N/A
- 52 Week Low
- PCG $14.99
- HLN $7.89
- 52 Week High
- PCG $21.72
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- PCG 53.56
- HLN 52.89
- Support Level
- PCG $15.57
- HLN $10.27
- Resistance Level
- PCG $16.50
- HLN $10.52
- Average True Range (ATR)
- PCG 0.37
- HLN 0.15
- MACD
- PCG 0.10
- HLN -0.03
- Stochastic Oscillator
- PCG 75.23
- HLN 46.46
About PCG Pacific Gas & Electric Co.
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision between January 2019 and June 2020. In 2004, PG&E sold its unregulated assets as part of an earlier postbankruptcy reorganization.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.